Authors:
KELSO EJ
MCDERMOTT BJ
SPIERS JP
SCHOLFIELD CN
SILKE B
Citation: Ej. Kelso et al., DIFFERENTIAL-EFFECTS OF NOVEL CARDIOTONIC AGENTS ON THE VENTRICULAR ACTION-POTENTIAL, British Journal of Pharmacology, 112, 1994, pp. 210000199-210000199
Citation: Na. Herity et al., COMPARISON OF THE ABILITY OF NICARDIPINE, THEOPHYLLINE AND ZAPRINAST TO RESTORE CARDIOVASCULAR HEMODYNAMICS FOLLOWING INHIBITION OF NITRIC-OXIDE SYNTHESIS, British Journal of Pharmacology, 112(2), 1994, pp. 423-428
Citation: Tck. Tham et al., HEMODYNAMIC COMPARISON OF AMLODIPINE AND ATENOLOL IN ESSENTIAL-HYPERTENSION USING THE QUANTASCOPE, British journal of clinical pharmacology, 36(6), 1993, pp. 555-560
Citation: Ej. Kelso et al., CARDIOTONIC ACTIONS OF THE NOVEL VASODILATOR, FLOSEQUINAN, AND ITS METABOLITE, BTS-53554, IN ISOLATED VENTRICULAR CARDIOMYOCYTES, British Journal of Pharmacology, 110, 1993, pp. 160000117-160000117
Citation: Ej. Kelso et al., CARDIOTONIC ACTIONS OF SELECTIVE PHOSPHODIESTERASE INHIBITORS IN RAT ISOLATED VENTRICULAR CARDIOMYOCYTES, British Journal of Pharmacology, 110(4), 1993, pp. 1387-1394
Citation: Ej. Kelso et al., CONTRACTILE MECHANISMS OF THE NOVEL PHOSPHODIESTERASE INHIBITOR, HN-10200, IN ISOLATED RAT VENTRICULAR CARDIOMYOCYTES, British Journal of Pharmacology, 109, 1993, pp. 160000125-160000125